Clinical value of circulating lipocalins and insulin-like growth factor axis in pancreatic cancer diagnosis

El-Mesallamy, Hala O; Prof. Hamdy, Nadia M.; Zaghloul, Ashraf S; Sallam, Alaliaa M;

Abstract


Early diagnosis of pancreatic cancer (PC) in diabetic patients is difficult owing to late presentation of symptoms. Hence, finding a marker to identify cancer stage early would be useful to improve survival. We aimed to determine levels of serum retinol binding protein 4 (RBP-4), neutrophil gelatinase-associated lipocalin (NGAL), insulin-like growth factor I (IGF-I), and its binding protein 3 (IGFBP-3) in patients with PC with preexisting type 2 diabetes. Moreover, we assessed their clinical usefulness in PC diagnosis and their association with tumor severity.


Other data

Title Clinical value of circulating lipocalins and insulin-like growth factor axis in pancreatic cancer diagnosis
Authors El-Mesallamy, Hala O; Prof. Hamdy, Nadia M. ; Zaghloul, Ashraf S; Sallam, Alaliaa M
Keywords IGF-I;insulin resistance;NGAL;pancreatic cancer;RBP-4
Issue Date Jan-2013
Journal Pancreas 
Volume 42
Issue 1
Start page 149
End page 154
ISSN 08853177
DOI 10.1097/MPA.0b013e3182550d9d
PubMed ID 22617715
Scopus ID 2-s2.0-84872083433

Recommend this item

Similar Items from Core Recommender Database

Google ScholarTM

Check



Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.